Detailed information for compound 783304

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 343.312 | Formula: C16H14FN5O3
  • H donors: 1 H acceptors: 4 LogP: 5.56 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: Cc1cccc(c1)n1nc(c([n+]1[O-])Nc1ccc(c(c1)F)C)[N+](=O)[O-]
  • InChi: 1S/C16H14FN5O3/c1-10-4-3-5-13(8-10)20-19-16(22(24)25)15(21(20)23)18-12-7-6-11(2)14(17)9-12/h3-9,18H,1-2H3
  • InChiKey: DJONOQMRFRXCLT-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis protein arginine N methyltransferase 8 0.0116 0.5117 1
Schistosoma mansoni protein arginine N-methyltransferase 1 0.0116 0.5117 1
Plasmodium falciparum protein arginine N-methyltransferase 1 0.0116 0.5117 1
Echinococcus granulosus protein arginine N methyltransferase 7 0.0065 0.133 0.26
Trypanosoma brucei Protein arginine N-methyltransferase 1 catalytic subunit 0.0181 1 1
Entamoeba histolytica arginine N-methyltransferase protein, putative 0.0181 1 1
Echinococcus multilocularis histone arginine methyltransferase CARMER 0.0065 0.133 0.26
Entamoeba histolytica arginine N-methyltransferase 1, putative 0.0065 0.133 0.133
Schistosoma mansoni hypothetical protein 0.0065 0.133 0.26
Toxoplasma gondii bicoid-interacting protein BIN3 0.0065 0.133 0.26
Trichomonas vaginalis protein arginine N-methyltransferase, putative 0.0116 0.5117 1
Toxoplasma gondii histone arginine methyltransferase PRMT4/CARM1 0.0065 0.133 0.26
Echinococcus multilocularis protein arginine methyltransferase 0.0116 0.5117 1
Echinococcus granulosus protein arginine N methyltransferase 8 0.0116 0.5117 1
Schistosoma mansoni protein arginine N-methyltransferase 1 0.0116 0.5117 1
Echinococcus granulosus histone arginine methyltransferase CARMER 0.0065 0.133 0.26
Leishmania major arginine N-methyltransferase-like protein 0.0116 0.5117 1
Trichomonas vaginalis protein arginine N-methyltransferase, putative 0.0116 0.5117 1
Trichomonas vaginalis protein arginine N-methyltransferase, putative 0.0116 0.5117 1
Entamoeba histolytica hypothetical protein 0.0181 1 1
Loa Loa (eye worm) hypothetical protein 0.0181 1 1
Loa Loa (eye worm) Carm1-pending protein 0.0065 0.133 0.133
Toxoplasma gondii histone arginine methyltransferase PRMT3 0.0065 0.133 0.26
Loa Loa (eye worm) protein arginine N-methyltransferase 0.0065 0.133 0.133
Echinococcus granulosus methyltransferase protein 5 0.0065 0.133 0.26
Trypanosoma cruzi arginine N-methyltransferase, putative 0.0181 1 1
Echinococcus granulosus protein arginine methyltransferase 0.0116 0.5117 1
Brugia malayi Protein arginine N-methyltransferase 0.0065 0.133 0.133
Schistosoma mansoni protein arginine N-methyltransferase 1 0.0116 0.5117 1
Trypanosoma cruzi arginine N-methyltransferase, putative 0.0181 1 1
Toxoplasma gondii histone arginine methyltransferase PRMT1 0.0116 0.5117 1
Brugia malayi Carm1-pending protein 0.0065 0.133 0.133
Plasmodium vivax protein arginine N-methyltransferase 1, putative 0.0116 0.5117 1
Schistosoma mansoni protein arginine n-methyltransferase 0.0065 0.133 0.26
Echinococcus multilocularis protein arginine N methyltransferase 7 0.0065 0.133 0.26

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.